Valuation Quoin Pharmaceuticals, Ltd.

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 06/03/2026 GMT			5-day change	1st Jan Change
8.670 ^USD	+1.17%		+3.58%	-39.92%

01-27	Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome	CI
01-20	Quoin, Inc. Announces Application for Breakthrough Medicine Designation with the SFDA for QRX003	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	15.19	6.883	4.842	5.328	14.6	14.6	-
Change	-	-54.69%	-29.65%	10.02%	173.99%	0%	-
Enterprise Value (EV)	15.19	6.883	4.842	5.328	14.6	14.6	14.6
Change	-	-54.69%	-29.65%	10.02%	173.99%	0%	0%
P/E ratio	-0.34x	-0.36x	-0.51x	-0.34x	-0.43x	-1.98x	-29.9x
PBR	-	-	-	-	-	-	-
PEG	-0x	0x	0x	0x	0x	0x	0.3x
Capitalization / Revenue	-	-	-	-	-	-	0.6x
EV / Revenue	-	-	-	-	-	-	0.6x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0.92x	-0.82x	-10.8x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-28,455	-1,638	-337.4	-66.85	-20.16	-4.38	-0.29
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	24.23
EBITDA	-	-	-	-	-	-	-
EBIT ¹	-6.063	-9.258	-9.378	-9.528	-15.8	-17.9	-1.351
Net income ¹	-21.46	-9.447	-8.687	-8.962	-15.44	-17.9	-1.351
Net Debt	-	-	-	-	-	-	-
Reference price ²	9,555.015	596.401	171.675	22.775	8.670	8.670	8.670
Nbr of stocks (in thousands)	1.59	11.5	28.2	234	1,684	1,684	-
Announcement Date	14/04/22	09/03/23	13/03/24	13/03/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
QUOIN PHARMACEUTICALS, LTD.	-0.43x	-	-	-	14.6M
LONZA GROUP AG	35.29x	5.14x	17.22x	0.97%	45.49B
BEONE MEDICINES AG	54.35x	4.68x	31.54x	-.--%	33.41B
CELLTRION, INC.	56.43x	11.55x	32.31x	0.34%	31.32B
IQVIA HOLDINGS INC.	21.15x	2.46x	10.59x	-.--%	29.29B
REVOLUTION MEDICINES, INC.	-12.85x	334.46x	-10.88x	-.--%	19.5B
ASCENDIS PHARMA A/S	45.29x	8.66x	27.2x	-.--%	14.77B
MEDPACE HOLDINGS, INC.	27.52x	4.39x	19.99x	-.--%	13.36B
EUROFINS SCIENTIFIC SE	21.12x	1.94x	8.48x	1.17%	13.21B
IONIS PHARMACEUTICALS, INC.	-18.31x	14.28x	-19.9x	-.--%	12.23B
Average	22.96x	43.06x	12.95x	0.28%	21.26B
Weighted average by Cap.	31.28x	36.38x	16.39x	0.33%